association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a103 |
loss_cnaPANCAN167 |
1012 |
1 |
1 |
Vorinostat |
HDAC inhibitor Class I, IIa, IIb, IV |
19 |
829 |
2.3 |
0.977 |
1.85 |
0.872 |
0.75 . |
0.76 . |
0.45 |
1.44e-05 |
2.19e-46 |
3.94e-01 |
2.3 |
a256 |
loss_cnaPANCAN167 |
231 |
1 |
1 |
FMK |
RSK |
15 |
777 |
3.00, 2.33 |
5 |
5.6 |
0.594 |
0.72 . |
0.72 . |
0.65 . |
1.6e-04 |
1.81e-40 |
4.77e-01 |
10 |
a384 |
loss_cnaPANCAN167 |
1049 |
1 |
1 |
PD-173074 |
FGFR1, FGFR3 |
19 |
827 |
0.693 |
2.57 |
3.3 |
0.731 |
0.66 . |
0.66 . |
0.96 . |
4.07e-04 |
2.24e-20 |
1.92e-01 |
18 |